Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer
- 9 January 2018
- journal article
- research article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 164 (3) , 351-355
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancerFrontiers of Medicine, 2017
- Novel miRNA genes hypermethylated in breast cancerMolecular Biology, 2016
- MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancerGene, 2016
- Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinomaBMC Cancer, 2015
- Upregulation of RHOA and NKIRAS1 genes in lung tumors is associated with loss of their methylation as well as with methylation of regulatory miRNA genesBiochemistry (Moscow), 2015
- Methylation of miRNA genes and oncogenesisBiochemistry (Moscow), 2015
- The Role of MicroRNAs in Ovarian CancerBioMed Research International, 2014
- Novel miRNA genes methylated in lung tumorsRussian Journal of Genetics, 2013
- Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1Gynecologic Oncology, 2012
- Epigenetic regulation of microRNAs in cancer: An integrated review of literatureMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2011